4.5 Article

Metagenomic Next-Generation Sequencing for the Diagnosis of Pneumocystis jirovecii Pneumonia in Non-HIV-Infected Patients: A Retrospective Study

期刊

INFECTIOUS DISEASES AND THERAPY
卷 10, 期 3, 页码 1733-1745

出版社

SPRINGER LONDON LTD
DOI: 10.1007/s40121-021-00482-y

关键词

Diagnosis; Metagenomics; Next-generation sequencing; Pneumocystis jirovecii; Pneumocystis jirovecii pneumonia

资金

  1. National Key R&D Program of China [2016YFC1304204]
  2. Project Program of National Clinical Research Center for Geriatric Disorders (Xiangya Hospital) [2020LNJJ05]
  3. National Natural Science Foundation of China [8160025]
  4. Natural Science Foundation of Hunan Province [S2019JJQNJJ1970]
  5. Youth Research Foundation of Xiangya Hospital [2018Q015]

向作者/读者索取更多资源

mNGS demonstrates high sensitivity and specificity in diagnosing PJP and detecting co-pathogens, suggesting its utility in bronchoalveolar lavage fluid and/or blood samples for patients suspected of PJP.
Introduction This study aimed to evaluate the utility of metagenomic next-generation sequencing (mNGS) for the diagnosis of Pneumocystis jirovecii pneumonia (PJP) in non-human immunodeficiency virus-infected patients. Methods We conducted a retrospective study. A total of 60 non-human immunodeficiency virus-infected PJP patients and 134 patients diagnosed with non-PJP pneumonia were included. P. jirovecii and other co-pathogens identified by mNGS in bronchoalveolar lavage fluid and/or blood samples were analyzed. Using clinical composite diagnosis as the reference standard, we compared the diagnostic performance of mNGS in PJP with conventional methods, including Gomori methenamine silver staining and serum (1,3)-beta-d-glucan. Modifications of antimicrobial treatment for PJP patients after the report of mNGS results were also reviewed. Results mNGS reached a sensitivity of 100% in diagnosing PJP, which was remarkably higher than Gomori methenamine silver staining (25.0%) and serum (1,3)-beta-d-glucan (67.4%). The specificity of mNGS (96.3%) significantly surpassed serum (1,3)-beta-d-glucan (81.4%). Simultaneous mNGS of bronchoalveolar lavage fluid and blood samples was performed in 21 out of 60 PJP patients, and it showed a concordance rate of 100% in detecting P. jirovecii. Besides, mNGS showed good performance in identifying co-pathogens of PJP patients, among which cytomegalovirus and Epstein-Barr virus were most commonly seen. Initial antimicrobial treatment was modified in 71.7% of PJP patients after the report of mNGS results. Conclusion mNGS is a useful diagnostic tool with good performance for the diagnosis of PJP and the detection of co-pathogens. mNGS of bronchoalveolar lavage fluid and/or blood samples is suggested in patients with presumptive diagnosis of PJP. Blood samples may be a good alternative to bronchoalveolar lavage fluid for mNGS when bronchoscopic examination is not feasible.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据